---
author: []
related: []
publisher:
  url: 'http://www.investorideas.com'
  name: Investorideas
  favicon: 'http://www.investorideas.com/favicon.ico'
  domain: www.investorideas.com
keywords:
  - tg-1101
  - tgr-1202
  - nmo
  - orphan
  - inhibitor
  - antibodies
  - therapeutics
  - drug
  - anti-gitr
  - investorideas
description: >-
  Biopharmaceutical News: TG Therapeutics (NASDAQ: $TGTX) Announces Orphan Drug
  Designation for TG-1101 for the Treatment of Neuromyelitis Optica and
  Neuromyelitis Optica Spectrum Disorder
inLanguage: en
app_links: []
isBasedOnUrl: 'http://www.investorideas.com/news/2016/biotech/08263TG.asp'
title: >-
  Investorideas.com - #Biopharmaceutical News: TG Therapeutics (NASDAQ: $TGTX)
  Announces Orphan Drug Designation for TG-1101 for the Treatment of
  Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder
datePublished: '2016-08-26T17:06:27.378Z'
dateModified: '2016-08-26T17:06:23.011Z'
via: {}
starred: false
sourcePath: _posts/2016-08-26-investorideascom-biopharmaceutical-news-tg-therapeutics.md
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>Investorideas.com - #Biopharmaceutical News: TG Therapeutics (NASDAQ: $TGTX) Announces Orphan Drug Designation for TG-1101 for the Treatment of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder</h1><p>Biopharmaceutical News: TG Therapeutics (NASDAQ: $TGTX) Announces Orphan Drug Designation for TG-1101 for the Treatment of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder</p><img src="http://www.investorideas.com/news/2016/biotech/images/082616-1.jpg" /></article>